Digital content products and technologies provider ebrary, US, has announced a new e-book programme for pharmaceutical companies that seeks to support their digital content needs through the entire product lifecycle. From R&D to manufacturing and distribution, to marketing and sales, ebrary provides the e-books and digital content services that can help pharmaceutical companies increase productivity, while extending their information budgets.
Currently available, ebrary's new programme includes a choice of models for acquiring e-books and other authoritative materials from publishers such as CRC Press, Elsevier Health Sciences, Informa Healthcare, Springer and Wiley; choose to subscribe with unlimited access, purchase individual titles; and buy based on employee usage. ebrary also offers many Doody's Core Titles; DASH! (Data Sharing, Fast); ebrary's do-it-yourself e-publishing tool; InfoTools and other research technologies; 24/7 web-based training with a real person; and complimentary marketing services.
To enable companies to stretch their budget dollars, ebrary recommends that pharmaceutical organisations subscribe to its new Pharmaceuticals Subscription E-book Database. The database seeks to provide simultaneous, multi-user access to a collection of more than 100 e-books on topics such as drug delivery, toxicology, clinical trials, drug safety, quality control, pricing and pharmaceutical marketing.
Companies may subsidise the subscription by purchasing individual titles in all key areas of the product lifecycle. Additionally, pharmaceutical companies may use DASH! to upload and enhance their collections with their own digital materials such as e-prints, product information, research reports, patents, proposals, government documents and competitive intelligence.
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
More News in this Theme
